Global Circulating Tumor Cell Market Size, Status and Forecast 2024-2031

Report ID: 955051 | Published Date: Jan 2025 | No. of Page: 128 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Circulating Tumor Cell Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 CTC Enrichment
        1.2.3 CTC Detection
        1.2.4 CTC Analysis
    1.3 Market by Application
        1.3.1 Global Circulating Tumor Cell Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Breast Cancer
        1.3.3 Prostate Cancer
        1.3.4 Colorectal Cancer
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Circulating Tumor Cell Market Perspective (2016-2027)
    2.2 Circulating Tumor Cell Growth Trends by Regions
        2.2.1 Circulating Tumor Cell Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Circulating Tumor Cell Historic Market Share by Regions (2016-2021)
        2.2.3 Circulating Tumor Cell Forecasted Market Size by Regions (2022-2027)
    2.3 Circulating Tumor Cell Industry Dynamic
        2.3.1 Circulating Tumor Cell Market Trends
        2.3.2 Circulating Tumor Cell Market Drivers
        2.3.3 Circulating Tumor Cell Market Challenges
        2.3.4 Circulating Tumor Cell Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Circulating Tumor Cell Players by Revenue
        3.1.1 Global Top Circulating Tumor Cell Players by Revenue (2016-2021)
        3.1.2 Global Circulating Tumor Cell Revenue Market Share by Players (2016-2021)
    3.2 Global Circulating Tumor Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Circulating Tumor Cell Revenue
    3.4 Global Circulating Tumor Cell Market Concentration Ratio
        3.4.1 Global Circulating Tumor Cell Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell Revenue in 2020
    3.5 Circulating Tumor Cell Key Players Head office and Area Served
    3.6 Key Players Circulating Tumor Cell Product Solution and Service
    3.7 Date of Enter into Circulating Tumor Cell Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Circulating Tumor Cell Breakdown Data by Type
    4.1 Global Circulating Tumor Cell Historic Market Size by Type (2016-2021)
    4.2 Global Circulating Tumor Cell Forecasted Market Size by Type (2022-2027)

5 Circulating Tumor Cell Breakdown Data by Application
    5.1 Global Circulating Tumor Cell Historic Market Size by Application (2016-2021)
    5.2 Global Circulating Tumor Cell Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Circulating Tumor Cell Market Size (2016-2027)
    6.2 North America Circulating Tumor Cell Market Size by Type
        6.2.1 North America Circulating Tumor Cell Market Size by Type (2016-2021)
        6.2.2 North America Circulating Tumor Cell Market Size by Type (2022-2027)
        6.2.3 North America Circulating Tumor Cell Market Size by Type (2016-2027)
    6.3 North America Circulating Tumor Cell Market Size by Application
        6.3.1 North America Circulating Tumor Cell Market Size by Application (2016-2021)
        6.3.2 North America Circulating Tumor Cell Market Size by Application (2022-2027)
        6.3.3 North America Circulating Tumor Cell Market Size by Application (2016-2027)
    6.4 North America Circulating Tumor Cell Market Size by Country
        6.4.1 North America Circulating Tumor Cell Market Size by Country (2016-2021)
        6.4.2 North America Circulating Tumor Cell Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Circulating Tumor Cell Market Size (2016-2027)
    7.2 Europe Circulating Tumor Cell Market Size by Type
        7.2.1 Europe Circulating Tumor Cell Market Size by Type (2016-2021)
        7.2.2 Europe Circulating Tumor Cell Market Size by Type (2022-2027)
        7.2.3 Europe Circulating Tumor Cell Market Size by Type (2016-2027)
    7.3 Europe Circulating Tumor Cell Market Size by Application
        7.3.1 Europe Circulating Tumor Cell Market Size by Application (2016-2021)
        7.3.2 Europe Circulating Tumor Cell Market Size by Application (2022-2027)
        7.3.3 Europe Circulating Tumor Cell Market Size by Application (2016-2027)
    7.4 Europe Circulating Tumor Cell Market Size by Country
        7.4.1 Europe Circulating Tumor Cell Market Size by Country (2016-2021)
        7.4.2 Europe Circulating Tumor Cell Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Circulating Tumor Cell Market Size (2016-2027)
    8.2 Asia-Pacific Circulating Tumor Cell Market Size by Type
        8.2.1 Asia-Pacific Circulating Tumor Cell Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Circulating Tumor Cell Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Circulating Tumor Cell Market Size by Type (2016-2027)
    8.3 Asia-Pacific Circulating Tumor Cell Market Size by Application
        8.3.1 Asia-Pacific Circulating Tumor Cell Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Circulating Tumor Cell Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Circulating Tumor Cell Market Size by Application (2016-2027)
    8.4 Asia-Pacific Circulating Tumor Cell Market Size by Region
        8.4.1 Asia-Pacific Circulating Tumor Cell Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Circulating Tumor Cell Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Circulating Tumor Cell Market Size (2016-2027)
    9.2 Latin America Circulating Tumor Cell Market Size by Type
        9.2.1 Latin America Circulating Tumor Cell Market Size by Type (2016-2021)
        9.2.2 Latin America Circulating Tumor Cell Market Size by Type (2022-2027)
        9.2.3 Latin America Circulating Tumor Cell Market Size by Type (2016-2027)
    9.3 Latin America Circulating Tumor Cell Market Size by Application
        9.3.1 Latin America Circulating Tumor Cell Market Size by Application (2016-2021)
        9.3.2 Latin America Circulating Tumor Cell Market Size by Application (2022-2027)
        9.3.3 Latin America Circulating Tumor Cell Market Size by Application (2016-2027)
    9.4 Latin America Circulating Tumor Cell Market Size by Country
        9.4.1 Latin America Circulating Tumor Cell Market Size by Country (2016-2021)
        9.4.2 Latin America Circulating Tumor Cell Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Circulating Tumor Cell Market Size (2016-2027)
    10.2 Middle East & Africa Circulating Tumor Cell Market Size by Type
        10.2.1 Middle East & Africa Circulating Tumor Cell Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Circulating Tumor Cell Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Circulating Tumor Cell Market Size by Type (2016-2027)
    10.3 Middle East & Africa Circulating Tumor Cell Market Size by Application
        10.3.1 Middle East & Africa Circulating Tumor Cell Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Circulating Tumor Cell Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Circulating Tumor Cell Market Size by Application (2016-2027)
    10.4 Middle East & Africa Circulating Tumor Cell Market Size by Country
        10.4.1 Middle East & Africa Circulating Tumor Cell Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Circulating Tumor Cell Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Menarini-Silicon Biosystems
        11.1.1 Menarini-Silicon Biosystems Company Details
        11.1.2 Menarini-Silicon Biosystems Business Overview
        11.1.3 Menarini-Silicon Biosystems Circulating Tumor Cell Introduction
        11.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cell Business (2016-2021)
        11.1.5 Menarini-Silicon Biosystems Recent Development
    11.2 Qiagen（Adnagen）
        11.2.1 Qiagen（Adnagen） Company Details
        11.2.2 Qiagen（Adnagen） Business Overview
        11.2.3 Qiagen（Adnagen） Circulating Tumor Cell Introduction
        11.2.4 Qiagen（Adnagen） Revenue in Circulating Tumor Cell Business (2016-2021)
        11.2.5 Qiagen（Adnagen） Recent Development
    11.3 Clearbridge Biomedics
        11.3.1 Clearbridge Biomedics Company Details
        11.3.2 Clearbridge Biomedics Business Overview
        11.3.3 Clearbridge Biomedics Circulating Tumor Cell Introduction
        11.3.4 Clearbridge Biomedics Revenue in Circulating Tumor Cell Business (2016-2021)
        11.3.5 Clearbridge Biomedics Recent Development
    11.4 Celsee
        11.4.1 Celsee Company Details
        11.4.2 Celsee Business Overview
        11.4.3 Celsee Circulating Tumor Cell Introduction
        11.4.4 Celsee Revenue in Circulating Tumor Cell Business (2016-2021)
        11.4.5 Celsee Recent Development
    11.5 Fluidigm
        11.5.1 Fluidigm Company Details
        11.5.2 Fluidigm Business Overview
        11.5.3 Fluidigm Circulating Tumor Cell Introduction
        11.5.4 Fluidigm Revenue in Circulating Tumor Cell Business (2016-2021)
        11.5.5 Fluidigm Recent Development
    11.6 ApoCell
        11.6.1 ApoCell Company Details
        11.6.2 ApoCell Business Overview
        11.6.3 ApoCell Circulating Tumor Cell Introduction
        11.6.4 ApoCell Revenue in Circulating Tumor Cell Business (2016-2021)
        11.6.5 ApoCell Recent Development
    11.7 Greiner Bio-one
        11.7.1 Greiner Bio-one Company Details
        11.7.2 Greiner Bio-one Business Overview
        11.7.3 Greiner Bio-one Circulating Tumor Cell Introduction
        11.7.4 Greiner Bio-one Revenue in Circulating Tumor Cell Business (2016-2021)
        11.7.5 Greiner Bio-one Recent Development
    11.8 Advanced Cell Diagnostics
        11.8.1 Advanced Cell Diagnostics Company Details
        11.8.2 Advanced Cell Diagnostics Business Overview
        11.8.3 Advanced Cell Diagnostics Circulating Tumor Cell Introduction
        11.8.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Business (2016-2021)
        11.8.5 Advanced Cell Diagnostics Recent Development
    11.9 Aviva Biosciences
        11.9.1 Aviva Biosciences Company Details
        11.9.2 Aviva Biosciences Business Overview
        11.9.3 Aviva Biosciences Circulating Tumor Cell Introduction
        11.9.4 Aviva Biosciences Revenue in Circulating Tumor Cell Business (2016-2021)
        11.9.5 Aviva Biosciences Recent Development
    11.10 Fluxion Biosciences
        11.10.1 Fluxion Biosciences Company Details
        11.10.2 Fluxion Biosciences Business Overview
        11.10.3 Fluxion Biosciences Circulating Tumor Cell Introduction
        11.10.4 Fluxion Biosciences Revenue in Circulating Tumor Cell Business (2016-2021)
        11.10.5 Fluxion Biosciences Recent Development
    11.11 Sysmex
        11.11.1 Sysmex Company Details
        11.11.2 Sysmex Business Overview
        11.11.3 Sysmex Circulating Tumor Cell Introduction
        11.11.4 Sysmex Revenue in Circulating Tumor Cell Business (2016-2021)
        11.11.5 Sysmex Recent Development
    11.12 Epic Sciences
        11.12.1 Epic Sciences Company Details
        11.12.2 Epic Sciences Business Overview
        11.12.3 Epic Sciences Circulating Tumor Cell Introduction
        11.12.4 Epic Sciences Revenue in Circulating Tumor Cell Business (2016-2021)
        11.12.5 Epic Sciences Recent Development
    11.13 Cynvenio
        11.13.1 Cynvenio Company Details
        11.13.2 Cynvenio Business Overview
        11.13.3 Cynvenio Circulating Tumor Cell Introduction
        11.13.4 Cynvenio Revenue in Circulating Tumor Cell Business (2016-2021)
        11.13.5 Cynvenio Recent Development
    11.14 CytoTrack
        11.14.1 CytoTrack Company Details
        11.14.2 CytoTrack Business Overview
        11.14.3 CytoTrack Circulating Tumor Cell Introduction
        11.14.4 CytoTrack Revenue in Circulating Tumor Cell Business (2016-2021)
        11.14.5 CytoTrack Recent Development
    11.15 Ikonisys
        11.15.1 Ikonisys Company Details
        11.15.2 Ikonisys Business Overview
        11.15.3 Ikonisys Circulating Tumor Cell Introduction
        11.15.4 Ikonisys Revenue in Circulating Tumor Cell Business (2016-2021)
        11.15.5 Ikonisys Recent Development
    11.16 Vortex BioSciences
        11.16.1 Vortex BioSciences Company Details
        11.16.2 Vortex BioSciences Business Overview
        11.16.3 Vortex BioSciences Circulating Tumor Cell Introduction
        11.16.4 Vortex BioSciences Revenue in Circulating Tumor Cell Business (2016-2021)
        11.16.5 Vortex BioSciences Recent Development
    11.17 Gilupi
        11.17.1 Gilupi Company Details
        11.17.2 Gilupi Business Overview
        11.17.3 Gilupi Circulating Tumor Cell Introduction
        11.17.4 Gilupi Revenue in Circulating Tumor Cell Business (2016-2021)
        11.17.5 Gilupi Recent Development
    11.18 Biocept
        11.18.1 Biocept Company Details
        11.18.2 Biocept Business Overview
        11.18.3 Biocept Circulating Tumor Cell Introduction
        11.18.4 Biocept Revenue in Circulating Tumor Cell Business (2016-2021)
        11.18.5 Biocept Recent Development
    11.18 ScreenCell
        .1 ScreenCell Company Details
        .2 ScreenCell Business Overview
        .3 ScreenCell Circulating Tumor Cell Introduction
        .4 ScreenCell Revenue in Circulating Tumor Cell Business (2016-2021)
        .5 ScreenCell Recent Development
    11.20 ANGLE
        11.20.1 ANGLE Company Details
        11.20.2 ANGLE Business Overview
        11.20.3 ANGLE Circulating Tumor Cell Introduction
        11.20.4 ANGLE Revenue in Circulating Tumor Cell Business (2016-2021)
        11.20.5 ANGLE Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Circulating Tumor Cell Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of CTC Enrichment
    Table 3. Key Players of CTC Detection
    Table 4. Key Players of CTC Analysis
    Table 5. Global Circulating Tumor Cell Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Circulating Tumor Cell Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Circulating Tumor Cell Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Circulating Tumor Cell Market Share by Regions (2016-2021)
    Table 9. Global Circulating Tumor Cell Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Circulating Tumor Cell Market Share by Regions (2022-2027)
    Table 11. Circulating Tumor Cell Market Trends
    Table 12. Circulating Tumor Cell Market Drivers
    Table 13. Circulating Tumor Cell Market Challenges
    Table 14. Circulating Tumor Cell Market Restraints
    Table 15. Global Circulating Tumor Cell Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Circulating Tumor Cell Market Share by Players (2016-2021)
    Table 17. Global Top Circulating Tumor Cell Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cell as of 2020)
    Table 18. Ranking of Global Top Circulating Tumor Cell Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Circulating Tumor Cell Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Circulating Tumor Cell Product Solution and Service
    Table 22. Date of Enter into Circulating Tumor Cell Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Circulating Tumor Cell Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Circulating Tumor Cell Revenue Market Share by Type (2016-2021)
    Table 26. Global Circulating Tumor Cell Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Circulating Tumor Cell Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Circulating Tumor Cell Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Circulating Tumor Cell Revenue Market Share by Application (2016-2021)
    Table 30. Global Circulating Tumor Cell Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Circulating Tumor Cell Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Circulating Tumor Cell Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Circulating Tumor Cell Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Circulating Tumor Cell Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Circulating Tumor Cell Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Circulating Tumor Cell Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Circulating Tumor Cell Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Circulating Tumor Cell Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Circulating Tumor Cell Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Circulating Tumor Cell Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Circulating Tumor Cell Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Circulating Tumor Cell Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Circulating Tumor Cell Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Circulating Tumor Cell Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Circulating Tumor Cell Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Circulating Tumor Cell Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Circulating Tumor Cell Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Circulating Tumor Cell Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Circulating Tumor Cell Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Circulating Tumor Cell Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Circulating Tumor Cell Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Circulating Tumor Cell Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Circulating Tumor Cell Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Circulating Tumor Cell Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Circulating Tumor Cell Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Circulating Tumor Cell Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Circulating Tumor Cell Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Circulating Tumor Cell Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Circulating Tumor Cell Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Circulating Tumor Cell Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Circulating Tumor Cell Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Menarini-Silicon Biosystems Company Details
    Table 63. Menarini-Silicon Biosystems Business Overview
    Table 64. Menarini-Silicon Biosystems Circulating Tumor Cell Product
    Table 65. Menarini-Silicon Biosystems Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 66. Menarini-Silicon Biosystems Recent Development
    Table 67. Qiagen（Adnagen） Company Details
    Table 68. Qiagen（Adnagen） Business Overview
    Table 69. Qiagen（Adnagen） Circulating Tumor Cell Product
    Table 70. Qiagen（Adnagen） Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 71. Qiagen（Adnagen） Recent Development
    Table 72. Clearbridge Biomedics Company Details
    Table 73. Clearbridge Biomedics Business Overview
    Table 74. Clearbridge Biomedics Circulating Tumor Cell Product
    Table 75. Clearbridge Biomedics Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 76. Clearbridge Biomedics Recent Development
    Table 77. Celsee Company Details
    Table 78. Celsee Business Overview
    Table 79. Celsee Circulating Tumor Cell Product
    Table 80. Celsee Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 81. Celsee Recent Development
    Table 82. Fluidigm Company Details
    Table 83. Fluidigm Business Overview
    Table 84. Fluidigm Circulating Tumor Cell Product
    Table 85. Fluidigm Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 86. Fluidigm Recent Development
    Table 87. ApoCell Company Details
    Table 88. ApoCell Business Overview
    Table 89. ApoCell Circulating Tumor Cell Product
    Table 90. ApoCell Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 91. ApoCell Recent Development
    Table 92. Greiner Bio-one Company Details
    Table 93. Greiner Bio-one Business Overview
    Table 94. Greiner Bio-one Circulating Tumor Cell Product
    Table 95. Greiner Bio-one Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 96. Greiner Bio-one Recent Development
    Table 97. Advanced Cell Diagnostics Company Details
    Table 98. Advanced Cell Diagnostics Business Overview
    Table 99. Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 100. Advanced Cell Diagnostics Recent Development
    Table 101. Aviva Biosciences Company Details
    Table 102. Aviva Biosciences Business Overview
    Table 103. Aviva Biosciences Circulating Tumor Cell Product
    Table 104. Aviva Biosciences Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 105. Aviva Biosciences Recent Development
    Table 106. Fluxion Biosciences Company Details
    Table 107. Fluxion Biosciences Business Overview
    Table 108. Fluxion Biosciences Circulating Tumor Cell Product
    Table 109. Fluxion Biosciences Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 110. Fluxion Biosciences Recent Development
    Table 111. Sysmex Company Details
    Table 112. Sysmex Business Overview
    Table 113. Sysmex Circulating Tumor Cell Product
    Table 114. Sysmex Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 115. Sysmex Recent Development
    Table 116. Epic Sciences Company Details
    Table 117. Epic Sciences Business Overview
    Table 118. Epic Sciences Circulating Tumor Cell Product
    Table 119. Epic Sciences Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 120. Epic Sciences Recent Development
    Table 121. Cynvenio Company Details
    Table 122. Cynvenio Business Overview
    Table 123. Cynvenio Circulating Tumor Cell Product
    Table 124. Cynvenio Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 125. Cynvenio Recent Development
    Table 126. CytoTrack Company Details
    Table 127. CytoTrack Business Overview
    Table 128. CytoTrack Circulating Tumor Cell Product
    Table 129. CytoTrack Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 130. CytoTrack Recent Development
    Table 131. Ikonisys Company Details
    Table 132. Ikonisys Business Overview
    Table 133. Ikonisys Circulating Tumor Cell Product
    Table 134. Ikonisys Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 135. Ikonisys Recent Development
    Table 136. Vortex BioSciences Company Details
    Table 137. Vortex BioSciences Business Overview
    Table 138. Vortex BioSciences Circulating Tumor Cell Product
    Table 139. Vortex BioSciences Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 140. Vortex BioSciences Recent Development
    Table 141. Gilupi Company Details
    Table 142. Gilupi Business Overview
    Table 143. Gilupi Circulating Tumor Cell Product
    Table 144. Gilupi Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 145. Gilupi Recent Development
    Table 146. Biocept Company Details
    Table 147. Biocept Business Overview
    Table 148. Biocept Circulating Tumor Cell Product
    Table 149. Biocept Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 150. Biocept Recent Development
    Table 151. ScreenCell Company Details
    Table 152. ScreenCell Business Overview
    Table 153. ScreenCell Circulating Tumor Cell Product
    Table 154. ScreenCell Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 155. ScreenCell Recent Development
    Table 156. ANGLE Company Details
    Table 157. ANGLE Business Overview
    Table 158. ANGLE Circulating Tumor Cell Product
    Table 159. ANGLE Revenue in Circulating Tumor Cell Business (2016-2021) & (US$ Million)
    Table 160. ANGLE Recent Development
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Circulating Tumor Cell Market Share by Type: 2020 VS 2027
    Figure 2. CTC Enrichment Features
    Figure 3. CTC Detection Features
    Figure 4. CTC Analysis Features
    Figure 5. Global Circulating Tumor Cell Market Share by Application: 2020 VS 2027
    Figure 6. Breast Cancer Case Studies
    Figure 7. Prostate Cancer Case Studies
    Figure 8. Colorectal Cancer Case Studies
    Figure 9. Others Case Studies
    Figure 10. Circulating Tumor Cell Report Years Considered
    Figure 11. Global Circulating Tumor Cell Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Circulating Tumor Cell Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Circulating Tumor Cell Market Share by Regions: 2020 VS 2027
    Figure 14. Global Circulating Tumor Cell Market Share by Regions (2022-2027)
    Figure 15. Global Circulating Tumor Cell Market Share by Players in 2020
    Figure 16. Global Top Circulating Tumor Cell Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cell as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Circulating Tumor Cell Revenue in 2020
    Figure 18. Global Circulating Tumor Cell Revenue Market Share by Type (2016-2021)
    Figure 19. Global Circulating Tumor Cell Revenue Market Share by Type (2022-2027)
    Figure 20. North America Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Circulating Tumor Cell Market Share by Type (2016-2027)
    Figure 22. North America Circulating Tumor Cell Market Share by Application (2016-2027)
    Figure 23. North America Circulating Tumor Cell Market Share by Country (2016-2027)
    Figure 24. United States Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Circulating Tumor Cell Market Share by Type (2016-2027)
    Figure 28. Europe Circulating Tumor Cell Market Share by Application (2016-2027)
    Figure 29. Europe Circulating Tumor Cell Market Share by Country (2016-2027)
    Figure 30. Germany Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Circulating Tumor Cell Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Circulating Tumor Cell Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Circulating Tumor Cell Market Share by Region (2016-2027)
    Figure 40. China Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Circulating Tumor Cell Market Share by Type (2016-2027)
    Figure 48. Latin America Circulating Tumor Cell Market Share by Application (2016-2027)
    Figure 49. Latin America Circulating Tumor Cell Market Share by Country (2016-2027)
    Figure 50. Mexico Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Circulating Tumor Cell Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Circulating Tumor Cell Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Circulating Tumor Cell Market Share by Country (2016-2027)
    Figure 56. Turkey Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Circulating Tumor Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Menarini-Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 60. Qiagen（Adnagen） Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 61. Clearbridge Biomedics Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 62. Celsee Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 63. Fluidigm Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 64. ApoCell Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 65. Greiner Bio-one Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 66. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 67. Aviva Biosciences Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 68. Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 69. Sysmex Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 70. Epic Sciences Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 71. Cynvenio Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 72. CytoTrack Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 73. Ikonisys Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 74. Vortex BioSciences Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 75. Gilupi Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 76. Biocept Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 77. ScreenCell Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 78. ANGLE Revenue Growth Rate in Circulating Tumor Cell Business (2016-2021)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Menarini-Silicon Biosystems
Qiagen（Adnagen）
Clearbridge Biomedics
Celsee
Fluidigm
ApoCell
Greiner Bio-one
Advanced Cell Diagnostics
Aviva Biosciences
Fluxion Biosciences
Sysmex
Epic Sciences
Cynvenio
CytoTrack
Ikonisys
Vortex BioSciences
Gilupi
Biocept
ScreenCell
ANGLE
Frequently Asked Questions
Circulating Tumor Cell report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Circulating Tumor Cell report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Circulating Tumor Cell report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports